Resection of liver metastases from colorectal cancer - How can we improve results?

Colorectal Disease

Volumn 5, Issue 5, 2003, Pages 515-517

  Nordlinger, Bernard ^a   Peschaud, F ^a   Malafosse, R ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Chemotherapy; Colorectal cancer; Liver metastases; Resection

Indexed keywords

ANTINEOPLASTIC AGENT; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; COLORECTAL CANCER; HIGH RISK PATIENT; HUMAN; LIVER METASTASIS; LIVER RESECTION; PATIENT SELECTION; PRIORITY JOURNAL; RECURRENCE RISK; SIDE EFFECT; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; LIVER NEOPLASMS; PATIENT SELECTION;

EID: 0041827192     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1318.2003.00514.x     Document Type: Article

References (17)

1. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy of primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 1992; 10: 904-11.
2. Douillard J-Y, Cunningham D, Roth A et al. Iirinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000; 355: 1041-7.
3. Saltz LB, Cox JV, Blanke C et al. Irinotecan plus fluorouracil and leucoverin for metastatic colorectal cancer. N Engl J Med 2000; 343: 905-15.
4. De Gramont A, Figer A, Seymour M et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-47.
5. Nordlinger B, Guiguet M, Vaillant JC et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996; 77: 1254-62.
6. Hughes K et al. Registry of hepatic metastases: resection of the liver for colorectal carcinoma metastases: a multi-institutional Study of indications for resection. Surgery 1988; 100: 270-88.
7. Fong Y, Fortner J, Sun RL et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-21.
8. Rougier P, Milan C, Lazorthes F et al. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Br J Surg 1995; 82: 1397-400.
9. Nordlinger B, Vaillant JC, Guiguet M et al. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. J Clin Oncol 1994; 12: 1491-6.
10. Randomized phase III study of local treatment of liver metastases by radiofrequency combined with chemotherapy versus chemotherapy alone in patients with unresectable colorectal liver metastases. EORTC Study 40004.
11. Kemeny MM, Sudeshna A, Gray B et al. Combined modality treatment for resecable metastatic colorectal carcinoma to the liver. Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-An intergroup study. J Clin Oncol 2002; 20: 1499-505.
12. Lorenz M, Muller HH, Schramm H et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-Fluorouracil and Folinic Acid for liver metastases of colorectal cancer. Ann Surg 1998; 28: 756-62.
13. Kemeny N, Huang Y, Cohen AM et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341: 2039-48.
14. Portier G, Rougier PJ, Milan C et al. Adjuvant systemic chemotherapy (CT) using 5-Fluorouracil (FU) and folinic acid (AA) after resection of liver metastases (LM) from colorectal (CRC) origin. Results of an intergroup phase III study (Trial FFCD - ACHBT - AURC 9002). Proc ASCO 2002; 21: 133a.
15. Langer B, Bleiberg H, Labianca R et al. Fluorouracil (FU) + I-Leucovorin (I-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. Proc ASCO 2002; 21: 149a.
16. Pre- and Post-Operative Chemotherapy with Oxaliplatin 5FU, /LV. versus Surgery alone in Resectable Liver Metastases from Colorectal Origin - Phase III Study. EORTC Trial 40983.
17. Giacchetti S, Itzhaki M, Gruia G et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999; 10: 663-9.